Association of PNPLA3 (rs738409 C>G) with liver damage in liver diseases: one step closer to personalized medicine?

Author： Trépo Eric   Franchimont Denis   Moreno Christophe  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.8, Iss.6, 2011-11, pp. : 595-597

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long‐term clinical outcome in chronic hepatitis B patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 438-447

John Wiley & Sons Inc

Access to resources Recommend Favorite

PNPLA3 polymorphisms (rs738409) and non‐alcoholic fatty liver disease risk and related phenotypes: a meta‐analysis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 5, 2015-05 ,pp. : 821-829

John Wiley & Sons Inc

Access to resources Recommend Favorite

PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 658-659

John Wiley & Sons Inc

Access to resources Recommend Favorite

PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non‐obese subjects with hepatitis C

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 10, 2015-05 ,pp. : 939-948

John Wiley & Sons Inc

Access to resources Recommend Favorite

Commentary: dissecting the PNPLA3 association with liver fat and stiffness, and interaction with diet

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 39, Iss. 8, 2014-04 ,pp. : 894-895

John Wiley & Sons Inc

Access to resources Recommend Favorite